eduKateSG · Why Science?
Turn a splicing graph into named events that a reader can inspect, compare and question
Reading routes
Science learning becomes useful when a familiar object or observation is turned into a system of quantities, mechanisms and claim limits. This guide owns one applied evidence-reading job inside eduKateSG’s wider Science estate. It connects naturally to Dexseq.Html; Why Science Deseq2 Moderated Dispersion Fold Change Count Data; Why Science Metaseqr2 Ensemble Evidence Rna Seq Workflows; Science Learning Hub; Education Hub; Careers By Subject Capability Career Pathways; How Education Works Stem Education. It also keeps current school and public claims traceable to visible primary sources: EventPointer foundational primary study; Official Bioconductor EventPointer package, release 3.23; Current official EventPointer vignette; 2026 Singapore–Cambridge O-Level Biology syllabus; MOE G2/G3 Lower Secondary Science syllabus; 2026 MOE G2 Computing syllabus. The sources describe the scientific scope; this article translates that scope into a calm route for Primary Science, PSLE Science, Secondary Science, O-Level Science, STEM exploration, school choices and career pathways without inventing admission or employment outcomes.
EventPointer is a current Bioconductor package for identifying alternative-splicing events in simple and complex designs. Its current documentation covers junction arrays and RNA-seq; for RNA-seq it can use annotated events or build a splicing graph and identify specific events. The original primary paper established the event-centred framework on junction arrays, while the current package extends the documented workflow to sequencing data. That history matters: readers should not casually attribute every current RNA-seq feature to the earlier validation study.
Inside this guide
1–12 · Foundations and models
- 1. Define the independent sample: Splicing Graph
- 2. Separate counts from molecules: Event Path
- 3. Write the contrast before analysis: Delta Psi
- 4. Name the uncertainty: Complex Design
- 5. State the central assumption: Novel Events
- 6. Keep the claim bounded: Domain Hypothesis
- 7. Read the official evidence in scope: Splicing Graph
- 8. Build a trustworthy count matrix: Event Path
- 9. Create a complete sample sheet: Delta Psi
- 10. Inspect library composition: Complex Design
- 11. Map sample relationships: Novel Events
- 12. Filter by information: Domain Hypothesis
13–24 · Evidence, testing and applications
- 13. Confirm the design can answer the question: Splicing Graph
- 14. Choose the comparison scale: Event Path
- 15. Practise with invented evidence: Delta Psi
- 16. Run the method reproducibly: Complex Design
- 17. Interpret the central output: Novel Events
- 18. Control the testing family: Domain Hypothesis
- 19. Read magnitude beside uncertainty: Splicing Graph
- 20. Plot every biological sample: Event Path
- 21. Inspect the decisive diagnostic: Delta Psi
- 22. Challenge the central assumption: Complex Design
- 23. Test filtering sensitivity: Novel Events
- 24. Test normalisation sensitivity: Domain Hypothesis
25–36 · Learning, decisions and pathways
- 25. Test sample influence: Splicing Graph
- 26. Test method settings: Event Path
- 27. Compare an adjacent method: Delta Psi
- 28. Build an evidence card: Complex Design
- 29. Connect to fair testing: Novel Events
- 30. Try a classroom investigation: Domain Hypothesis
- 31. Connect to mathematics: Splicing Graph
- 32. Connect to computing literacy: Event Path
- 33. Connect to education pathways: Delta Psi
- 34. Ask the family question: Complex Design
- 35. Use precise scientific language: Novel Events
- 36. Finish with a reproducible bundle: Domain Hypothesis
Section 1 of 36
1. Define the independent sample: Splicing Graph
Start with the experimental unit and the question. A polished differential-expression table is only as strong as the sampling design that produced its columns.
EventPointer centres the analysis on interpretable alternative-splicing events represented by paths through a splicing graph. For this method, record both the observation that supports the step and the pattern that would weaken it.
Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.
Section 2 of 36
2. Separate counts from molecules: Event Path
Treat the count matrix as a chain of measurements: extraction, library construction, sequencing, alignment or quantification, annotation and summarisation all shape the number you see.
The current package documentation covers cassette exons, alternative splice sites, intron retention and other named event types. For this method, record both the observation that supports the step and the pattern that would weaken it.
Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.
Section 3 of 36
3. Write the contrast before analysis: Delta Psi
Write the biological comparison, reference level and covariates before opening the results. This blocks the weak habit of designing a contrast around the most colourful plot.
For RNA-seq, the package can work with annotated events or construct a splicing graph and identify events from sequencing evidence. For this method, record both the observation that supports the step and the pattern that would weaken it.
Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.
Section 4 of 36
4. Name the uncertainty: Complex Design
Separate biological variability, sampling noise, technical processing and model uncertainty. Each enters the evidence differently and none is cancelled by a large feature list.
The package reports event identity, genomic position, statistical evidence and a change in percent spliced in where applicable. For this method, record both the observation that supports the step and the pattern that would weaken it.
Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.
Section 5 of 36
5. State the central assumption: Novel Events
Name the assumption that lets the method learn across genes or samples. Once it is visible, diagnostics and sensitivity checks become purposeful rather than ritual.
A graph edge is supported by measurement and annotation choices; it is not automatically a complete transcript molecule. For this method, record both the observation that supports the step and the pattern that would weaken it.
Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.
Section 6 of 36
6. Keep the claim bounded: Domain Hypothesis
Keep the conclusion at the level measured. A computational ranking can guide validation; it does not prove cellular mechanism or clinical importance.
Complex designs such as paired or time-course studies require design and contrast matrices that match the biological sampling structure. For this method, record both the observation that supports the step and the pattern that would weaken it.
Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.
Section 7 of 36
7. Read the official evidence in scope: Splicing Graph
Read the primary paper beside the current official package documentation. The paper explains evaluated evidence; the package page describes the software that exists now.
The foundational paper validated the event-centred idea on junction arrays, while later package functionality includes RNA-seq; those evidence scopes must stay separate. For this method, record both the observation that supports the step and the pattern that would weaken it.
Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.
Section 8 of 36
8. Build a trustworthy count matrix: Event Path
Use documented non-negative integer counts with unique feature identifiers. Record genome and annotation releases, counting rules and strandedness so silent mismatches are discoverable.
Potential protein-domain effects are hypotheses for interpretation and follow-up, not direct protein measurements. For this method, record both the observation that supports the step and the pattern that would weaken it.
Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.
Section 9 of 36
9. Create a complete sample sheet: Delta Psi
Match every matrix column to one metadata row. Include condition, batch, subject, time, sex, processing order and pairing where scientifically relevant.
Novel-event discovery expands the testing universe, so annotation, filtering and multiplicity control must be reported together. For this method, record both the observation that supports the step and the pattern that would weaken it.
Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.
Section 10 of 36
10. Inspect library composition: Complex Design
Inspect totals, detected features, zeros and dominant genes. A few abundant features can alter the comparative scale even when no code produces an error.
Percent-spliced-in change is an effect scale; its uncertainty and sample-level consistency matter beside a threshold. For this method, record both the observation that supports the step and the pattern that would weaken it.
Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.
Section 11 of 36
11. Map sample relationships: Novel Events
Use ordination, correlations and sample-distance views as questions, not verdicts. Investigate surprising clusters against provenance before excluding any observation.
Event-level methods help readers ask a concrete structural question rather than treating every transcript label as equally identifiable. For this method, record both the observation that supports the step and the pattern that would weaken it.
Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.
Section 12 of 36
12. Filter by information: Domain Hypothesis
Apply a declared information filter before testing and preserve the retained universe. Filtering changes estimation and the number of decisions receiving multiplicity correction.
Orthogonal validation may use targeted RT-PCR, long-read sequencing or protein assays according to the ambiguity that remains. For this method, record both the observation that supports the step and the pattern that would weaken it.
Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.
Section 13 of 36
13. Confirm the design can answer the question: Splicing Graph
Check that the design matrix has independent information for every requested effect. Perfect condition–batch confounding has no unique statistical solution.
EventPointer centres the analysis on interpretable alternative-splicing events represented by paths through a splicing graph. For this method, record both the observation that supports the step and the pattern that would weaken it.
Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.
Section 14 of 36
14. Choose the comparison scale: Event Path
Choose scaling and offsets from biology and diagnostics rather than the number of discoveries. Save the factors because they are part of the evidence.
The current package documentation covers cassette exons, alternative splice sites, intron retention and other named event types. For this method, record both the observation that supports the step and the pattern that would weaken it.
Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.
Section 15 of 36
15. Practise with invented evidence: Delta Psi
The table below is a fictional classroom example, visibly labelled so it cannot be mistaken for a study result.
| Fictional event | Event type | Delta PSI | Adjusted p-value | Reading |
|---|---|---|---|---|
| EVT-17 | Cassette exon | +0.21 | 0.018 | Supported event change |
| EVT-29 | Alternative 3′ site | -0.05 | 0.420 | Weak evidence |
| EVT-44 | Intron retention | +0.16 | 0.047 | Validate independently |
For RNA-seq, the package can work with annotated events or construct a splicing graph and identify events from sequencing evidence. Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.
Section 16 of 36
16. Run the method reproducibly: Complex Design
Record the package release, function calls, arguments, factor levels and seeds. A reproducible command history is a scientific explanation another analyst can challenge.
The package reports event identity, genomic position, statistical evidence and a change in percent spliced in where applicable. For this method, record both the observation that supports the step and the pattern that would weaken it.
Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.
Section 17 of 36
17. Interpret the central output: Novel Events
Read the method-specific statistic together with its sign and units. Confirm which level is the reference before writing increase or decrease.
A graph edge is supported by measurement and annotation choices; it is not automatically a complete transcript molecule. For this method, record both the observation that supports the step and the pattern that would weaken it.
Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.
Section 18 of 36
18. Control the testing family: Domain Hypothesis
Control false discoveries across all genes and planned contrasts. A threshold selected after browsing the ranking is not a prespecified decision rule.
Complex designs such as paired or time-course studies require design and contrast matrices that match the biological sampling structure. For this method, record both the observation that supports the step and the pattern that would weaken it.
Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.
Section 19 of 36
19. Read magnitude beside uncertainty: Splicing Graph
Show fold change or another effect beside adjusted evidence and uncertainty. Statistical detectability and biological importance are not synonyms.
The foundational paper validated the event-centred idea on junction arrays, while later package functionality includes RNA-seq; those evidence scopes must stay separate. For this method, record both the observation that supports the step and the pattern that would weaken it.
Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.
Section 20 of 36
20. Plot every biological sample: Event Path
Plot every independent sample behind each headline feature. Means and model lines can hide outliers, inconsistent direction and sparse support.
Potential protein-domain effects are hypotheses for interpretation and follow-up, not direct protein measurements. For this method, record both the observation that supports the step and the pattern that would weaken it.
Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.
Section 21 of 36
21. Inspect the decisive diagnostic: Delta Psi
Choose a diagnostic that attacks the method’s defining assumption. A dashboard is useful only when each panel can change a decision.
Novel-event discovery expands the testing universe, so annotation, filtering and multiplicity control must be reported together. For this method, record both the observation that supports the step and the pattern that would weaken it.
Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.
Section 22 of 36
22. Challenge the central assumption: Complex Design
Ask what pattern would make the core assumption false, then look for it. Scientific confidence grows from surviving serious alternatives, not repeating one fit.
Percent-spliced-in change is an effect scale; its uncertainty and sample-level consistency matter beside a threshold. For this method, record both the observation that supports the step and the pattern that would weaken it.
Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.
Section 23 of 36
23. Test filtering sensitivity: Novel Events
Repeat a small set of defensible count filters and record changes in sign, rank and adjusted evidence.
Event-level methods help readers ask a concrete structural question rather than treating every transcript label as equally identifiable. For this method, record both the observation that supports the step and the pattern that would weaken it.
Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.
Section 24 of 36
24. Test normalisation sensitivity: Domain Hypothesis
Compare justified normalisation choices with the same samples, feature universe and contrast. Explain consequential reversals rather than hiding them.
Orthogonal validation may use targeted RT-PCR, long-read sequencing or protein assays according to the ambiguity that remains. For this method, record both the observation that supports the step and the pattern that would weaken it.
Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.
Section 25 of 36
25. Test sample influence: Splicing Graph
Where replication permits, leave out one biological sample at a time. A discovery that disappears with one sample needs narrower language.
EventPointer centres the analysis on interpretable alternative-splicing events represented by paths through a splicing graph. For this method, record both the observation that supports the step and the pattern that would weaken it.
Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.
Section 26 of 36
26. Test method settings: Event Path
Vary only settings supported by the documentation and question. Do not tune until a preferred gene crosses a threshold.
The current package documentation covers cassette exons, alternative splice sites, intron retention and other named event types. For this method, record both the observation that supports the step and the pattern that would weaken it.
Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.
Section 27 of 36
27. Compare an adjacent method: Delta Psi
Compare an adjacent method after aligning inputs and contrasts. Differences are clues about assumptions, not an automatic contest with one universal winner.
For RNA-seq, the package can work with annotated events or construct a splicing graph and identify events from sequencing evidence. For this method, record both the observation that supports the step and the pattern that would weaken it.
Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.
Section 28 of 36
28. Build an evidence card: Complex Design
Summarise provenance, design, preprocessing, model, estimate, uncertainty, diagnostics, sensitivities and validation in one compact evidence card.
The package reports event identity, genomic position, statistical evidence and a change in percent spliced in where applicable. For this method, record both the observation that supports the step and the pattern that would weaken it.
Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.
Section 29 of 36
29. Connect to fair testing: Novel Events
This is the same logic as a fair school experiment: control what can be controlled, record what cannot, repeat independent units and separate observation from explanation.
A graph edge is supported by measurement and annotation choices; it is not automatically a complete transcript molecule. For this method, record both the observation that supports the step and the pattern that would weaken it.
Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.
Section 30 of 36
30. Try a classroom investigation: Domain Hypothesis
A safe classroom model can make the invisible assumption tangible without pretending to reproduce a laboratory sequencing experiment.
Draw a three-node splicing graph with two possible paths. Give each group fictional junction counts, ask them to estimate which path becomes more common, and list the evidence a graph alone cannot provide. The activity is a learning model, not an RNA-seq experiment, diagnostic test or health claim.
Complex designs such as paired or time-course studies require design and contrast matrices that match the biological sampling structure. Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.
Section 31 of 36
31. Connect to mathematics: Splicing Graph
Ratios, logarithms, distributions, smoothing, shrinkage and multiple-testing correction turn a biological question into quantities that can be checked.
The foundational paper validated the event-centred idea on junction arrays, while later package functionality includes RNA-seq; those evidence scopes must stay separate. For this method, record both the observation that supports the step and the pattern that would weaken it.
Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.
Section 32 of 36
32. Connect to computing literacy: Event Path
Scripts make identifiers, filters, factor levels and versions inspectable. Computing literacy means understanding how code changes the claim, not merely making code run.
Potential protein-domain effects are hypotheses for interpretation and follow-up, not direct protein measurements. For this method, record both the observation that supports the step and the pattern that would weaken it.
Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.
Section 33 of 36
33. Connect to education pathways: Delta Psi
RNA-seq connects biology, statistics and computing. It can illuminate study routes in life science, biotechnology and data analysis without promising admission or a career outcome.
Novel-event discovery expands the testing universe, so annotation, filtering and multiplicity control must be reported together. For this method, record both the observation that supports the step and the pattern that would weaken it.
Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.
Section 34 of 36
34. Ask the family question: Complex Design
A useful family question is simple: how many independent biological samples support this result, and which assumption most affects the ranking?
Percent-spliced-in change is an effect scale; its uncertainty and sample-level consistency matter beside a threshold. For this method, record both the observation that supports the step and the pattern that would weaken it.
Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.
Section 35 of 36
35. Use precise scientific language: Novel Events
Write that the analysis supports differential expression or an association under the stated design and method. Avoid cause, cure, diagnosis or mechanism unless separate evidence justifies them.
Event-level methods help readers ask a concrete structural question rather than treating every transcript label as equally identifiable. For this method, record both the observation that supports the step and the pattern that would weaken it.
Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.
Section 36 of 36
36. Finish with a reproducible bundle: Domain Hypothesis
Deliver counts or stable accessions, metadata, annotations, code, settings, complete results, plots, sensitivity analyses, package versions and the narrowest defensible interpretation.
Orthogonal validation may use targeted RT-PCR, long-read sequencing or protein assays according to the ambiguity that remains. For this method, record both the observation that supports the step and the pattern that would weaken it.
Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.
Source date and scope note
Primary studies and current official software documentation were checked for this article on 11 October 2026. Package interfaces, dependencies and recommendations can change; consult the linked current release page and guide before reproduction.
Did You Know?
Two analyses can use the same RNA-seq samples yet ask different questions: total gene abundance, relative exon usage, a named splicing event, a time-course profile or a variance-component association. Scientific literacy begins by naming the question before comparing the answers.
Final reader checklist
Confirm the independent biological sample count, design, measured material, annotation, preprocessing, statistical unit, exact contrast, effect scale, uncertainty, controls, sensitivity checks, validation plan and the boundary between association and causation.
Contents · Previous section · Continue to the Science Learning Hub
